These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 35913551)
1. Food supplementation based on potassium citrate, magnesium and probiotics reduces crystalluria in patients undergoing endourological surgery for stone disease: report from a pilot study. Vittori M; Signoretti M; Cipriani C; Antonucci M; Ferraro PM; Bove P Urolithiasis; 2022 Oct; 50(5):651-652. PubMed ID: 35913551 [No Abstract] [Full Text] [Related]
2. Alkali Citrate Content of Common Over-the-Counter and Medical Food Supplements. Dai JC; Maalouf NM; Hill K; Antonelli JA; Pearle MS; Johnson BA J Endourol; 2023 Jan; 37(1):112-118. PubMed ID: 35972746 [No Abstract] [Full Text] [Related]
3. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Tungsanga K; Sriboonlue P; Futrakul P; Yachantha C; Tosukhowong P Urol Res; 2005 Feb; 33(1):65-9. PubMed ID: 15565439 [TBL] [Abstract][Full Text] [Related]
4. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336 [TBL] [Abstract][Full Text] [Related]
5. The importance of citrates in treatment and prophylaxis of calcium oxalate urinary stones. Barbera M; Tsirgiotis A; Barbera M; Paola Q Arch Ital Urol Androl; 2016 Dec; 88(4):343-344. PubMed ID: 28073210 [TBL] [Abstract][Full Text] [Related]
6. In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts. Mairiang E; Hanpanich P; Sriboonlue P Magn Reson Imaging; 2004 Jun; 22(5):715-9. PubMed ID: 15172066 [TBL] [Abstract][Full Text] [Related]
7. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Caudarella R; Vescini F Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682 [TBL] [Abstract][Full Text] [Related]
8. Citrate and renal calculi: new insights and future directions. Pak CY Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910 [TBL] [Abstract][Full Text] [Related]
9. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176 [TBL] [Abstract][Full Text] [Related]
10. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
11. [A COMPARISON BETWEEN TWO POTASSIUM CITRATE REGIMENS FOR THE TREATMENT OF NEPHROLITHIASIS]. Drori T; Abu-Ghanem Y; Kleinmann N; Shvero A; Winkler HZ; Zilberman DE Harefuah; 2019 Dec; 158(12):774-777. PubMed ID: 31823528 [TBL] [Abstract][Full Text] [Related]
12. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041 [TBL] [Abstract][Full Text] [Related]
13. Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism. Tosukhowong P; Tungsanga K; Phongudom S; Sriboonlue P Int J Urol; 2005 Feb; 12(2):140-4. PubMed ID: 15733107 [TBL] [Abstract][Full Text] [Related]
14. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Ruml LA; Pak CY Am J Kidney Dis; 1999 Jul; 34(1):107-13. PubMed ID: 10401023 [TBL] [Abstract][Full Text] [Related]
15. Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects. Vongpatanasin W; Peri-Okonny P; Velasco A; Arbique D; Wang Z; Ravikumar P; Adams-Huet B; Moe OW; Pak CYC Am J Cardiol; 2016 Sep; 118(6):849-853. PubMed ID: 27448942 [TBL] [Abstract][Full Text] [Related]
16. Citrate and renal calculi: an update. Pak CY Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699 [TBL] [Abstract][Full Text] [Related]
17. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria. Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777 [TBL] [Abstract][Full Text] [Related]
18. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Lojanapiwat B; Tanthanuch M; Pripathanont C; Ratchanon S; Srinualnad S; Taweemonkongsap T; Kanyok S; Lammongkolkul S Int Braz J Urol; 2011; 37(5):611-6. PubMed ID: 22099273 [TBL] [Abstract][Full Text] [Related]
19. Effects of non-pharmacological interventions on urinary citrate levels: a systematic review and meta-analysis. Pachaly MA; Baena CP; Buiar AC; de Fraga FS; Carvalho M Nephrol Dial Transplant; 2016 Aug; 31(8):1203-11. PubMed ID: 26311217 [TBL] [Abstract][Full Text] [Related]
20. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate. Koenig K; Padalino P; Alexandrides G; Pak CY J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]